Long-term Safety and Efficacy of Roflumilast Cream 0.3% in Adult Patients With Chronic Plaque Psoriasis: Results From a 52-Week, Phase 2b Open-Label Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 6, p. s44, 2021. DOI: 10.25251/skin.5.supp.44. Disponível em: https://skin.dermsquared.com/skin/article/view/1395. Acesso em: 9 may. 2026.